Yasushi Totoki

Yasushi Totoki

Auto-generated profile, based on publicly available information

Yasushi Totoki

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
SYShinichi Yachida
Shinichi Yachida
YTYasushi Totoki
Yasushi Totoki
MNMichaël Noë
Michaël Noë
YNYoichiro Nakatani
Yoichiro Nakatani
MHMasafumi Horie
Masafumi Horie
TSTatsuhiro Shibata
Tatsuhiro Shibata
The neuroendocrine carcinoma of the gastrointestinal system (GIS-NEC) is a rare but highly malignant neoplasm. We analyzed 115 cases using whole-genome/exome sequencing, transcriptome sequencing, DNA methylation assays, and/or ATAC-seq and found GIS-NECs to be genetically distinct from neuroendocrine tumors (GIS-NET) in the same location. Clear genomic differences were also evident between pancreatic NECs (Panc-NEC) and nonpancreatic GIS-NECs (Nonpanc-NEC). Panc-NECs could be classified into two subgroups (i.e., “ductal-type” and “acinar-type”) based on genomic features. Alterations in TP53 and RB1 proved common in GIS-NECs, and most Nonpanc-NECs with intact RB1 demonstrated mutually exclusive amplification of CCNE1 or MYC. Alterations of the Notch gene family were characteristic of Nonpanc-NECs. Transcription factors for neuroendocrine differentiation, especially the SOX2 gene, appeared overexpressed in most GIS-NECs due to hypermethylation of the promoter region. This first comprehensive study of genomic alterations in GIS-NECs uncovered several key biological processes underlying genesis of this very lethal form of cancer. Significance: GIS-NECs are genetically distinct from GIS-NETs. GIS-NECs arising in different organs show similar histopathologic features and share some genomic features, but considerable differences exist between Panc-NECs and Nonpanc-NECs. In addition, Panc-NECs could be classified into two subgroups (i.e., “ductal-type” and “acinar-type”) based on genomic and epigenomic features. This article is highlighted in the In This Issue feature, p. 587

13 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YTYasushi Totoki
Yasushi Totoki
MSMihoko Saito-Adachi
Mihoko Saito-Adachi
YSYuichi Shiraishi
Yuichi Shiraishi
DKDaisuke Komura
Daisuke Komura
HNHiromi Nakamura
Hiromi Nakamura
TSTatsuhiro Shibata
Tatsuhiro Shibata

8 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
ASAkihiro Suzuki
Akihiro Suzuki
HKHiroto Katoh
Hiroto Katoh
DKDaisuke Komura
Daisuke Komura
MKMiwako Kakiuchi
Miwako Kakiuchi
ATAmane Tagashira
Amane Tagashira
HAHiroyuki Aburatani
Hiroyuki Aburatani
Germline and environmental effects on the development of gastric cancers (GC) and their ethnic differences have been poorly understood. Here, we performed genomic-scale trans-ethnic analysis of 531 GCs (319 Asian and 212 non-Asians). There was one distinct GC subclass with clear alcohol-associated mutation signature and strong Asian specificity, almost all of which were attributable to alcohol intake behavior, smoking habit, and Asian-specific defective ALDH2 allele. Alcohol-related GCs have low mutation burden and characteristic immunological profiles. In addition, we found frequent (7.4%) germline CDH1 variants among Japanese GCs, most of which were attributed to a few recurrent single-nucleotide variants shared by Japanese and Koreans, suggesting the existence of common ancestral events among East Asians. Specifically, approximately one-fifth of diffuse-type GCs were attributable to the combination of alcohol intake and defective ALDH2 allele or to CDH1 variants. These results revealed uncharacterized impacts of germline variants and lifestyles in the high incidence areas.

16 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAkihiko Fukagawa
Akihiko Fukagawa
NHNatsuko Hama
Natsuko Hama
YTYasushi Totoki
Yasushi Totoki
HNHiromi Nakamura
Hiromi Nakamura
YAYasuhito Arai
Yasuhito Arai
TSTatsuhiro Shibata
Tatsuhiro Shibata
Renal cell carcinoma (RCC) comprises several histological types characterised by different genomic and epigenomic aberrations; however, the molecular pathogenesis of each type still requires further exploration. We perform whole-genome sequencing of 128 Japanese RCC cases of different histology to elucidate the significant somatic alterations and mutagenesis processes. We also perform transcriptomic and epigenomic sequencing to identify distinguishing features, including assay for transposase-accessible chromatin sequencing (ATAC-seq) and methyl sequencing. Genomic analysis reveals that the mutational signature differs among the histological types, suggesting that different carcinogenic factors drive each histology. From the ATAC-seq results, master transcription factors are identified for each histology. Furthermore, clear cell RCC is classified into three epi-subtypes, one of which expresses highly immune checkpoint molecules with frequent loss of chromosome 14q. These genomic and epigenomic features may lead to the development of effective therapeutic strategies for RCC.

22 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMihoko Saito-Adachi
Mihoko Saito-Adachi
NHNatsuko Hama
Natsuko Hama
YTYasushi Totoki
Yasushi Totoki
HNHiromi Nakamura
Hiromi Nakamura
YAYasuhito Arai
Yasuhito Arai
TSTatsuhiro Shibata
Tatsuhiro Shibata
Structural variants (SVs) are responsible for driver events in gastric cancer (GC); however, their patterns and processes remain poorly understood. Here, we examine 170 GC whole genomes to unravel the oncogenic structural aberration landscape in GC genomes and identify six rearrangement signatures (RSs). Non-random combinations of RSs elucidate distinctive GC subtypes comprising one or a few dominant RS that are associated with specific driver events (BRCA1/2 defects, mismatch repair deficiency, and TP53 mutation) and epidemiological backgrounds. Twenty-seven SV hotspots are identified as GC driver candidates. SV hotspots frequently constitute complexly clustered SVs involved in driver gene amplification, such as ERBB2, CCNE1, and FGFR2. Further deconstruction of the locally clustered SVs uncovers amplicon-generating profiles characterized by super-large SVs and intensive segmental amplifications, contributing to the extensive amplification of GC oncogenes. Comprehensive analyses using adjusted SV allele frequencies indicate the significant involvement of extra-chromosomal DNA in processes linked to specific RSs.

21 January 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SSShotaro Sakimura
Shotaro Sakimura
SNSatoshi Nagayama
Satoshi Nagayama
MFMitsuko Fukunaga
Mitsuko Fukunaga
QHQingjiang Hu
Qingjiang Hu
AKAkihiro Kitagawa
Akihiro Kitagawa
KMKoshi Mimori
Koshi Mimori
A Darwinian evolutionary shift occurs early in the neutral evolution of advanced colorectal carcinoma (CRC), and copy number aberrations (CNA) are essential in the transition from adenoma to carcinoma. In light of this primary evolution, we investigated the evolutionary principles of the genome that foster postoperative recurrence of CRC. CNA and neoantigens (NAG) were compared between early primary tumors with recurrence (CRCR) and early primary tumors without recurrence (precancerous and early; PCRC). We compared CNA, single nucleotide variance (SNV), RNA sequences, and T-cell receptor (TCR) repertoire between 9 primary and 10 metastatic sites from 10 CRCR cases. We found that NAG in primary sites were fewer in CRCR than in PCRC, while the arm level CNA were significantly higher in primary sites in CRCR than in PCRC. Further, a comparison of genomic aberrations of primary and metastatic conditions revealed no significant differences in CNA. The driver mutations in recurrence were the trunk of the evolutionary phylogenic tree from primary sites to recurrence sites. Notably, PD-1 and TIM3, T cell exhaustion-related molecules of the tumor immune response, were abundantly expressed in metastatic sites compared to primary sites along with the increased number of CD8 expressing cells. The postoperative recurrence-free survival period was only significantly associated with the NAG levels and TCR repertoire diversity in metastatic sites. Therefore, CNA with diminished NAG and diverse TCR repertoire in pre-metastatic sites may determine postoperative recurrence of CRC.